Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 17/20 | 0.70 |
| ▸ | MMP9 | P14780 | 12/20 | 0.70 |
| ▸ | MMP8 | P22894 | 9/20 | 0.70 |
| ▸ | MMP1 | P03956 | 9/20 | 0.70 |
| ▸ | MMP14 | P50281 | 2/20 | 0.68 |
| ▸ | MMP3 | P08254 | 2/20 | 0.68 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.68 |
| ▸ | ADAM12 | O43184 | 1/20 | 0.68 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.68 |
| ▸ | MMP7 | P09237 | 1/20 | 0.68 |
| ▸ | MMP12 | P39900 | 1/20 | 0.68 |
| ▸ | MMP13 | P45452 | 1/20 | 0.68 |
| ▸ | MMP15 | P51511 | 1/20 | 0.68 |
| ▸ | MMP16 | P51512 | 1/20 | 0.68 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.68 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.68 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.68 |
| ▸ | MMP17 | Q9ULZ9 | 1/20 | 0.68 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6439250 | 0.90 | MMP2 (0.80) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL7765890 | 0.90 | MMP2 (0.80) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL6577614 | 0.90 | MMP2 (0.80) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL6575453 | 0.87 | MMP2 (0.72) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL851449 | 0.83 | MMP2 (0.82) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL6578096 | 0.83 | MMP2 (0.82) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL6577793 | 0.83 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP14 | |
| SCHEMBL6431194 | 0.82 | ECE1 (0.79) | MMP2MMP9MMP8MMP1MMP14 | |
| Ilomastat SCHEMBL4293696 | 0.81 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP14 | |
| Ilomastat SCHEMBL8190117 | 0.81 | MMP2 (1.00) | MMP2MMP9MMP8MMP1MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558648-B1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 2004-04-28 | — | — | EP | disclosed |
| EP-0663823-B1 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INC (US) | 2000-11-22 | — | — | EP | disclosed |
| EP-0663823-A4 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0663823-A1 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED INCORPORATED (US) | 1995-07-26 | — | — | EP | disclosed |
| WO-1994022309-A1 | SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS AND USES THEREOF | GLYCOMED INCORPORATED (US) | 1994-10-13 | — | — | WO | disclosed |
| US-5268384-A | Containing amide groups | GLYCOMED, INC., A CA CORP | 1993-12-07 | — | — | US | disclosed |
| EP-0558635-A4 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | — | 1993-11-24 | — | — | EP | disclosed |
| EP-0558648-A4 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | — | 1993-11-24 | — | — | EP | disclosed |
| EP-0558648-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY, Richard, E. (US) | 1993-09-08 | — | — | EP | disclosed |
| EP-0558635-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS. | GLYCOMED INC (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5239078-A | Collagenase enzyme inhibitors | GLYCOMED INCORPORATED (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1993013741-A2 | INHIBITION OF ANGIOGENESIS BY SYNTHETIC MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1993-07-22 | — | — | WO | disclosed |
| WO-1992009556-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GALARDY RICHARD E (US) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009563-A1 | IMPROVED MATRIX METALLOPROTEASE INHIBITORS | GLYCOMED, INC. (US) | 1992-06-11 | — | — | WO | disclosed |